摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-tert-butyl 6-methyl (1R*,4S*,6R*)-2-azabicyclo[2.2.2]octane-2,6-dicarboxylate | 125136-76-7

中文名称
——
中文别名
——
英文名称
2-tert-butyl 6-methyl (1R*,4S*,6R*)-2-azabicyclo[2.2.2]octane-2,6-dicarboxylate
英文别名
(1S,4R,6S)-2-tert-Butyl 6-methyl 2-azabicyclo[2.2.2]octane-2,6-dicarboxylate;2-O-tert-butyl 6-O-methyl (1R,4S,6R)-2-azabicyclo[2.2.2]octane-2,6-dicarboxylate
2-tert-butyl 6-methyl (1R*,4S*,6R*)-2-azabicyclo[2.2.2]octane-2,6-dicarboxylate化学式
CAS
125136-76-7
化学式
C14H23NO4
mdl
——
分子量
269.341
InChiKey
VMDDWBSYOBGVND-HBNTYKKESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    55.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Novel 5-HT3 antagonists. Indole oxadiazoles
    摘要:
    The synthesis and biochemical evaluation of a series of indole oxadiazole 5-HT3 antagonists are described. The key pharmacophoric elements have been defined as a basic nitrogen, a linking group capable of H-bonding interactions, and an aromatic moiety. The steric limitations of the aromatic binding site have been determined by substitution about the indole ring. Variation of the heterocyclic linking group has shown that while two hydrogen-bonding interactions are possible, only one is essential for high affinity. The environment of the basic nitrogen has been investigated and shown to be optimal when constrained within an azabicyclic system. These results have been incorporated into a proposed binding model for the 5-HT3 antagonist binding site, in which the optimum distance between the aromatic binding site and the basic amine is 8.4-8.9 angstrom and the steric limitations are defined by van der Waals difference mapping.
    DOI:
    10.1021/jm00105a021
  • 作为产物:
    描述:
    6-benzyl 2-methyl (1RS,4RS,6RS)-2-azabicyclo[2.2.2]oct-7-ene-2,6-dicarboxylate 在 palladium on activated charcoal 氯化亚砜碘代三甲硅烷氢气三乙胺 作用下, 以 甲醇氯仿 为溶剂, 反应 145.5h, 生成 2-tert-butyl 6-methyl (1R*,4S*,6R*)-2-azabicyclo[2.2.2]octane-2,6-dicarboxylate
    参考文献:
    名称:
    Stereospecific Synthesis of New 4-Amino-1,2,3-cyclohexanetricarboxylic Acids and 4-Amino-1,3-cyclohexanedicarboxylic Acids
    摘要:
    1,2-二氢吡啶与马来酸和丙烯酸衍生物的Diels-Alder加合物通过RuO4氧化反应,以立体选择性方式转化为新的4-氨基-1,2,3-环己烷三羧酸和4-氨基-1,3-环己烷二羧酸。
    DOI:
    10.1248/cpb.53.81
点击查看最新优质反应信息

文献信息

  • 3-substituted sulfonyl piperidine derivative
    申请人:MSD K.K.
    公开号:US08188280B2
    公开(公告)日:2012-05-29
    [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R1 represents C1-6 alkyl, C3-8 cycloalkyl, or the like; R2 represents aryl or heteroaryl; R3 represents a hydrogen atom, C1-6 alkyl, or the like; and M1, M2, M3, and M4 independently represent a hydrogen atom, C1-6 alkyl, or the like, or M1, together with M2, M3, or M4, forms —CH2— or the like.
    【问题】提供了一种化合物,可用作心血管疾病、神经疾病、代谢性疾病、生殖疾病和消化疾病的预防或治疗药物。【解决方法】一种化合物或其药学上可接受的盐,其表示如下式(I):其中Z表示:其中n1,n2和n3分别为0、1或2;R1表示C1-6烷基,C3-8环烷基或类似物;R2表示芳基或杂环芳基;R3表示氢原子,C1-6烷基或类似物;M1、M2、M3和M4分别独立地表示氢原子,C1-6烷基或类似物,或M1与M2、M3或M4一起形成—CH2—或类似物。
  • 3-SUBSTITUTED SULFONYL PIPERIDINE DERIVATIVE
    申请人:Nagase Tsuyoshi
    公开号:US20100331360A1
    公开(公告)日:2010-12-30
    [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R 1 represents C 1-6 alkyl, C 3-8 cycloalkyl, or the like; R 2 represents aryl or heteroaryl; R 3 represents a hydrogen atom, C 1-6 alkyl, or the like; and M 1 , M 2 , M 3 , and M 4 independently represent a hydrogen atom, C 1-6 alkyl, or the like, or M 1 , together with M 2 , M 3 , or M 4 , forms —CH 2 — or the like.
    [问题] 提供了一种化合物,可用作心血管疾病、神经疾病、代谢性疾病、生殖疾病和消化疾病的预防或治疗药物。[解决方法] 化合物或其药学上可接受的盐由以下式(I)表示,其中Z代表其中n1、n2和n3分别为0、1或2;R1代表C1-6烷基、C3-8环烷基或类似物;R2代表芳基或杂环芳基;R3代表氢原子、C1-6烷基或类似物;M1、M2、M3和M4独立地表示氢原子、C1-6烷基或类似物,或M1与M2、M3或M4一起形成-CH2-或类似物。
  • 3-SUBSTITUTED SULFONYL PIPERAZINE DERIVATIVE
    申请人:MSD K.K.
    公开号:EP2261210B1
    公开(公告)日:2014-10-22
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺